Big changes

Anonymous

Guest
It's time for big changes at Cubist. Stock is down to 60.85 off it's high of 82.12. This group of clowns has wiped out 1/3 of shareholder value. MB should be voted out as CEO at next proxy meeting. Cubist needs a new set of eyes for the next phase of growth. Sales are stagnant, innovation is lagging and vision is blurred. The only thing that can save the company is a merger with a Pfizer, Merck or J&J. Management has tried to buy it's way to shareholder value but these acquisitions have been just a band aid for lack of sales. The investor community has been waiting on returns to justify the high P/E and it's not happening, eventually you have to deliver or look at a merger to bring back shareholder value. This group is lucky Carl Icahn doesn't own a substantial stake in this company, we need some activist shareholders. When your proxy comes let your voice be heard!
 






It's time for big changes at Cubist. Stock is down to 60.85 off it's high of 82.12. This group of clowns has wiped out 1/3 of shareholder value. MB should be voted out as CEO at next proxy meeting. Cubist needs a new set of eyes for the next phase of growth. Sales are stagnant, innovation is lagging and vision is blurred. The only thing that can save the company is a merger with a Pfizer, Merck or J&J. Management has tried to buy it's way to shareholder value but these acquisitions have been just a band aid for lack of sales. The investor community has been waiting on returns to justify the high P/E and it's not happening, eventually you have to deliver or look at a merger to bring back shareholder value. This group is lucky Carl Icahn doesn't own a substantial stake in this company, we need some activist shareholders. When your proxy comes let your voice be heard!

Uh, Mr. Activist. At proxy time you vote for Board members, not the CEO. The CEO serves the Board. But go ahead with your b$tchy post and keen Wall Street insight.
 






It's time for big changes at Cubist. Stock is down to 60.85 off it's high of 82.12. This group of clowns has wiped out 1/3 of shareholder value. MB should be voted out as CEO at next proxy meeting. Cubist needs a new set of eyes for the next phase of growth. Sales are stagnant, innovation is lagging and vision is blurred. The only thing that can save the company is a merger with a Pfizer, Merck or J&J. Management has tried to buy it's way to shareholder value but these acquisitions have been just a band aid for lack of sales. The investor community has been waiting on returns to justify the high P/E and it's not happening, eventually you have to deliver or look at a merger to bring back shareholder value. This group is lucky Carl Icahn doesn't own a substantial stake in this company, we need some activist shareholders. When your proxy comes let your voice be heard!

The biggest change for today is for you to change your diaper. Grow up. you sound like a true blow hard.
 












Here comes the changes! CEO is out, would have liked to see an outsider as CEO. Now it's time to maximize shareholder value and look for a buyout partner. Time for shareholders to finally get a return on investment. Shire is willing to overpay let's get it done!!!
 






Here comes the changes! CEO is out, would have liked to see an outsider as CEO. Now it's time to maximize shareholder value and look for a buyout partner. Time for shareholders to finally get a return on investment. Shire is willing to overpay let's get it done!!!

You dumbass go troll another site! Mike stepping down is not a news flash! Had been in the plans a long time!
 






Uh, Mr. Activist. At proxy time you vote for Board members, not the CEO. The CEO serves the Board. But go ahead with your b$tchy post and keen Wall Street insight.

Mr. Activist here, The official line will ask each of you to continue your efforts in the field, you have to show Wall Street that as a sales force you can deliver during this time of flux. Remember you are auditioning for your future employer and your actions and words will speak volumes. Merck has a good organizational structure in place with a young CEO. I hope that the long tenured can reap the benefits of equity. These acquisitions happen, nothing personal it's business. The board has a fiduciary duty to deliver a return to folks like me, we stake quite a bit on the company and are due a return . Good luck in the future.
 


















Mr. Activist here, The official line will ask each of you to continue your efforts in the field, you have to show Wall Street that as a sales force you can deliver during this time of flux. Remember you are auditioning for your future employer and your actions and words will speak volumes. Merck has a good organizational structure in place with a young CEO. I hope that the long tenured can reap the benefits of equity. These acquisitions happen, nothing personal it's business. The board has a fiduciary duty to deliver a return to folks like me, we stake quite a bit on the company and are due a return . Good luck in the future.

Merck is a joke. I wouldn't let my fat ugly ex-girlfriend work for them. Micro-managed, PCP reps rolling their stupid samples and promotional items in those bobo roller luggage units that all the Merkettes use. You don't have autonomy. you have to work in clusters and deal with pre-madonna's who think they sell more or work harder than anybody else. Bonus payout at plan is 20K. Chump change for us. Cannot believe we would accept such a bogus, one-sided deal. Hate Merck and Pfizer. Asshole company with asshole managers